A Hub for Health Innovation
Fueled by world-class health and research institutes and more than 2,500 companies in this key sector, the Netherlands boasts one of the most concentrated life sciences regions in the world. And with nearly 1,000 jobs added as a result of investments from multinational medical technology, pharmaceutical and biotech companies in 2016, Holland’s life sciences and health hub just keeps getting stronger.
Global medical technology company Medtronic started construction last year on a new distribution facility in Heerlen, the Netherlands. Located next to the company’s existing Center of Excellence, the 355,200-square-foot facility will begin operations in 2017 and create 140 new jobs in addition to the existing 1,000 jobs Medtronic has in Heerlen.
U.S. pharmaceutical company Merck (MSD) announced plans in August 2016 to invest €50 million to expand its existing biotech manufacturing capabilities in Oss, the Netherlands. The expansion of production is expected to create 30 new jobs. Over the last several years, the company has invested roughly €220 million in the Oss facility.
The Chinese medical technology company BrosMed Medical opened an office in Hoevelaken, in the Dutch province of Gelderland in May 2016. The office will focus on European marketing and sales activities as well as on providing a home base from which to coordinate international medical regulations.
A pair of young South African entrepreneurs, Annemie and Justin Fourie, established the European headquarters for their company, Handle Hands, at CIC in Rotterdam, the European arm of Massachusetts-based Cambridge Innovation Center (CIC). Handle Hands will develop and produce a range of products that help to optimize hand function, with multiple applications in the healthcare and medical segments, as well as the consumer market.